Troels Koch

USPTO Granted Patents = 25 (Patent Applications = 19)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 18)

Average Co-Inventor Count = 4.7

ph-index = 13

Forward Citations = 837(Granted Patents)

Location History:

Kobenhaven, DK (2000)
Kopenhagen, DK (2000 - 2001)
Kobenhaven S, DK (2001)
Kopenhagen S., DK (2002)
Kobenhaven S., DK (2003)
København S, DK (2009 - 2011)
København, DK (2013)
Copenhagen, DK (2000 - 2018)
Horsholm, DK (2020)
Hørsholm, DK (2023)

Company Filing History:

Roche Innovation Center Copenhagen A/s

patents

2 out of 480

Roche Diagnostics Gmbh

Georgia Tech Research Corporation

7. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11597926 - Thiophosphoramidites (2023-03-07),

2. 10815481 - Chiral library screen (2020-10-27),

3. 9994850 - Antisense design (2018-06-12),

4. 9951333 - Antisense design (2018-04-24),

5. 9890383 - Antisense design (2018-02-13),

6. 9738894 - Short interfering RNA (siRNA) analogues (2017-08-22),

7. 9708614 - Antisense design (2017-07-18),

8. 9428534 - Antisense design (2016-08-30),

9. 9297010 - Short interfering RNA (siRNA) analogues (2016-03-29),

10. 9045518 - Amino-LNA, thio-LNA and alpha-L-oxy-LN (2015-06-02),

11. 8653252 - Short interfering RNA (siRNA) analogues (2014-02-18),

12. 8492390 - Synthesis of locked nucleic acid derivatives (2013-07-23),

13. 8084458 - Synthesis of locked nucleic acid derivatives (2011-12-27),

14. 7687617 - Oligonucleotides with alternating segments of locked and non-locked nucleotides (2010-03-30),

15. 7569575 - Synthesis of locked nucleic acid derivatives (2009-08-04),

Title: Unveiling the Remarkable Contributions of Inventor Troels Koch

Introduction: Troels Koch, a prolific inventor based in Copenhagen, DK, has left an indelible mark in the field of innovations with his extraordinary work. With an impressive tally of 25 patents under his belt, Koch has significantly contributed to the realm of science and technology.

Latest Patents: Among his recent inventions, Koch introduced groundbreaking patents such as "Thiophosphoramidites," revolutionizing the manufacturing process of oligonucleotides. Moreover, his invention of the "Chiral library screen" method has paved the way for identifying phosphorothioate oligonucleotide variants with reduced toxicity, marking a significant advancement in the field.

Career Highlights: Koch's noteworthy career includes tenure at renowned companies such as Santaris Pharma A/S and Roche Innovation Center Copenhagen A/S. His expertise and dedication have been instrumental in driving innovation and shaping the landscape of scientific advancements.

Collaborations: Throughout his career, Koch has collaborated closely with esteemed professionals, including his esteemed coworkers Henrik Frydenlund Hansen and Christoph Rosenbohm. Together, they have spearheaded groundbreaking projects and propelled the boundaries of scientific research.

Conclusion: In conclusion, Troels Koch's inventive genius and unwavering commitment to excellence have solidified his position as a trailblazer in the world of innovations. His remarkable contributions continue to inspire and redefine the possibilities within the realms of science and technology.

This text is generated by artificial intelligence and may not be accurate.